Susan Abushakra – Biography
Last update: January 22, 2026Executive profile
Susan was Chief Medical Officer and D5 Program Leader at Transition Therapeutics, and Chief Medical Officer and D5 Development Leader at Perrigo Pharmaceuticals.
Susan Abushakra is currentlyChief Medical Officer at Alzheon - View - Alzheon org chart
Create your alert
to follow the career of Susan Abushakra.
Education
Susan Abushakra has a Residency Research Fellowship from Johns Hopkins University School of Medicine and a Degree esidency Neurology from Johns Hopkins Medical Institutions.
They have also studied at Johns Hopkins University School of Medicine :
Find more alumni from Johns Hopkins University School of Medicine
More about Susan Abushakra
Selected links
Do you need to know more about Susan Abushakra? More results.
Participate
Social media
- Susan Abushakra on Google News, X (Twitter), LinkedIn, YouTube
- View the pictures of Susan Abushakra
The colleagues of Susan Abushakra
Company Colleagues
- At Alzheon, Susan Abushakra has 21 colleagues including Martin Tolar (CEO & Director), Diane Jorkasky (Director)…
Industry Colleagues
- In the Biotechnology industry, Susan Abushakra has 35,762 colleagues in 2,407 companies located in 42 countries. 16,856 executive movements have been recorded in the last 12 months. Learn more about Biotechnology.
Report an error
Update the org chart details of Susan Abushakra.
Get in Touch
Here are a few tips for establishing great contacts.
